OBI received notice from patent attorney’s office that product patent for OBI-822 named “Compound and Compositions of Carbohydrate Vaccine and Uses Thereof” has been approved by Taiwan Intellectual Property Office

Relationship to the Company (please enter “head office” or “subsidiaries”): Head office

Reciprocal shareholding ratios: N/A

Cause of occurrence: OBI received notice from patent attorney’s office that product patent for OBI-822 named ” Compound and Compositions of Carbohydrate Vaccine and Uses Thereof” has been approved by Taiwan Intellectual Property Office (No. 103131876).